Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical impact of minocycline on afatinib-related rash in patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations.

Respiratory investigation - 1 Mar 2018

Goto Ayano, Ozawa Yuichi, Koda Keigo, Akahori Daisuke, Koyauchi Takashi, Amano Yusuke, Kakutani Takuya, Sato Yoshiko, Hasegawa Hirotsugu, Matsui Takashi, Yokomura Koshi, Suda Takafumi

Abstract excerpt

BACKGROUND: The management of skin toxicity is crucial for efficient afatinib treatment, but the role of tetracycline class antibiotics (TCs) in managing these rashes is relatively unknown. METHODS: We reviewed the clinical records of patients who were administered afatinib for the treatment of non-small cell lung cancer harboring epidermal growth factor receptor mutations between October 2014 and November 2016....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Diarrhea

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Epidermal Growth Factor

Share to Exanthema

Share to Minocycline

Share to Pyridines

Share to Severity of Illness Index

Share to Thiazoles

Source

Identifiers

PMID: 29548657
DOI: 10.1016/j.resinv.2017.11.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Clinical impact of minocycline on afatinib-related rash in patients with non-small cell lung cancer harboring epidermal growth factor receptor mutations.PMID 29548657Read ↗

Pulsed Azithromycin for the Treatment of Dacomitinib Induced Skin Toxicity in Patient with Tetracycline Intolerance – A Case ReportSemantic proximity Read ↗

Minocycline prevents and repairs the skin disorder associated with afatinib, one of the epidermal growth factor receptor-tyrosine kinase inhibitors for non-small cell lung cancerSemantic proximity Read ↗

Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experience.Semantic proximity Read ↗

Tetracyclines increase the survival of NSCLC patients treated with EGFR TKIs: a retrospective nationwide registry study.Semantic proximity Read ↗

[Toxicity associated with EGRF inhibition: review and key aspects in the management of afatinib].Semantic proximity Read ↗

Drug-induced Hypersensitivity Syndrome by EGFR-TKI in a Patient with Lung Cancer.Semantic proximity Read ↗

Afatinib-associated Stevens-Johnson syndrome in an EGFR-mutated lung cancer patient.Semantic proximity Read ↗

[Retrospective Analysis of the Afatinib Clinical Pathway during the 28-Day Introductory Period-The Japanese Style of Collaborative Drug Therapy Management(J-CDTM)].Semantic proximity Read ↗

Toxic epidermal necrolysis syndrome induced by tigecycline: a case report.Semantic proximity Read ↗

Combination of available topical beta-blockers and antibiotic ointment for epidermal growth factor receptor tyrosine kinase inhibitor-induced paronychia and pseudopyogenic granulomas in Taiwan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.